<- Back to digest

JOA - 2026-11-09 - Journal Article; Review

The Prognostic Implication of Preoperative Troponin Elevation at Hospital Admission in Hip Fracture Patients: A Systematic Review and Meta-Analysis.

Baldy de Sousa F, Pasqualotto E, Pasqualotto T, Martins EC, de Almeida Osterne F, Baldy Dos Reis F

meta-analysisLOE IIIn = 5 studies, 2,148 patientsSubgroup analyses at 1 month and 3 months; overall follow-up duration not uniformly reported across included studies.

Topics

arthroplastytrauma
PMID: 43003362DOI: 10.1016/j.arth.2026.11.034View on PubMed ->

Key Takeaway

Elevated admission troponin in hip fracture patients is associated with a 2.11-fold increased overall mortality risk (95% CI 1.63–2.74), with 1-month mortality risk nearly 3.65-fold higher than in troponin-normal patients.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This systematic review and meta-analysis evaluated whether preoperative admission troponin elevation predicts mortality and cardiac complications in hip fracture patients. Five observational studies (N=2,148) were pooled; elevated troponin was associated with RR 2.11 for overall mortality, RR 3.65 at 1 month, and RR 1.98 at 3 months. No significant differences were found between groups for arrhythmia, congestive heart failure, or length of stay.

Key Limitation

Only 5 heterogeneous observational studies were available, with non-standardized troponin assay types and cutoff thresholds across studies, limiting the ability to define a clinically actionable troponin threshold for risk stratification.

Original Abstract

BACKGROUND

The purpose of our study was to evaluate the prognostic significance of preoperative troponin elevation in patients who have hip fractures.

METHODS

PubMed, Embase, and the Cochrane Library were systematically searched for randomized controlled trials (RCTs) or observational studies published up to December 2025 comparing patients who have elevated cardiac troponin levels at hospital admission with those presenting normal troponin levels in patients who have hip fractures. Risk ratios (RR) were used to evaluate binary outcomes and mean differences (MD) for continuous endpoints, with 95% confidence intervals (CI).

RESULTS

A total of five studies comprising 2,148 patients who had hip fractures were included. The group with normal troponin at admission had significantly lower overall mortality compared to the group with elevated troponin (RR 2.11; 95% CI 1.63 to 2.74; P < 0.01). In a subgroup analysis, mortality at one month (RR 3.65; 95% CI 1.59 to 8.39; P < 0.01) and three months (RR 1.98; 95% CI 1.51 to 2.60; P < 0.01) was also significantly lower in patients with normal troponin at hospital admission. However, there were no significant differences between groups for arrhythmia, congestive heart failure, or lengths of hospital stay.

CONCLUSIONS

Preoperative elevation of cardiac troponin at hospital admission was consistently associated with an increased risk of mortality, supported by low to moderate-certainty evidence. These findings support the potential role of admission troponin as an accessible prognostic biomarker for early risk stratification in this high-risk population.